Idiopathic non-lupus full-house nephropathy

disease
On this page

Also known as Idiopathic non-lupus FHN

Summary

Idiopathic non-lupus full-house nephropathy (MONDO:0035763) is a disease. A subtype of kidney disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 22

Clinical features

Signs & symptoms

Clinical features (HPO)

22 HPO clinical features (Orphanet curated; top 22 by frequency):

HPO IDTermFrequency
HP:0000093ProteinuriaVery frequent (80-99%)
HP:0000083Renal insufficiencyFrequent (30-79%)
HP:0000100Nephrotic syndromeFrequent (30-79%)
HP:0000822HypertensionFrequent (30-79%)
HP:0004431Complement deficiencyFrequent (30-79%)
HP:0005421Decreased circulating complement C3 concentrationFrequent (30-79%)
HP:0045042Decreased circulating complement C4 concentrationFrequent (30-79%)
HP:0000099GlomerulonephritisOccasional (5-29%)
HP:0000155Oral ulcerOccasional (5-29%)
HP:0000988Skin rashOccasional (5-29%)
HP:0001369ArthritisOccasional (5-29%)
HP:0001919Acute kidney injuryOccasional (5-29%)
HP:0001966Mesangial abnormalityOccasional (5-29%)
HP:0002907Microscopic hematuriaOccasional (5-29%)
HP:0003259Elevated circulating creatinine concentrationOccasional (5-29%)
HP:0012576Glomerular C3 depositionOccasional (5-29%)
HP:0045073SerositisOccasional (5-29%)
HP:0100769SynovitisOccasional (5-29%)
HP:0002960AutoimmunityExcluded (0%)
HP:0020151Anti-dsDNA antibody positivityExcluded (0%)
HP:0000707Abnormality of the nervous systemVery rare (<1-4%)
HP:0002715Abnormality of the immune systemVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical nameidiopathic non-lupus full-house nephropathy
Mondo IDMONDO:0035763
Orphanet567544
UMLSC5680132
MedGen1830099
GARD0022285
Is cancer (heuristic)no

Also known as: Idiopathic non-lupus FHN

Disease family

This is a subtype of kidney disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › urinary system disorderkidney disorderidiopathic non-lupus full-house nephropathy

Related subtypes (56): renal hypertension, kidney failure, nephritis, impaired renal function disease, nephrocalcinosis, atheroembolism of kidney, renal artery disease, nephrosis, cystic kidney disease, anuria, stricture or kinking of ureter, proteinuria, renal infectious disease, diabetes insipidus, orthostatic proteinuria, kidney hypertrophy, chronic kidney disease, hydronephrosis, renal tubular transport disease, kidney cortex necrosis, kidney papillary necrosis, perinephritis, renal aminoaciduria, autosomal dominant progressive nephropathy with hypertension, nephrolithiasis, X-linked diffuse leiomyomatosis-Alport syndrome, tubulointerstitial nephritis and uveitis syndrome, distal renal tubular acidosis, oligomeganephronia, duplication of urethra, renal tubular dysgenesis, exstrophy-epispadias complex, fetal lower urinary tract obstruction, IgG4-related kidney disease, congenital primary megaureter, renal nutcracker syndrome, renal hypoplasia, renal dysplasia, congenital megacalycosis, glomerular disorder, congenital renal artery stenosis, kidney neoplasm, renal tubule disorder, pyonephrosis, Arnold stickler bourne syndrome, C1q nephropathy, hypertensive nephropathy, atypical Fanconi syndrome-neonatal hyperinsulinism syndrome, lachiewicz sibley syndrome, crush syndrome, obstructive nephropathy, inherited kidney disorder, acute tubulointerstitial nephritis, kidney cortex disease, non-syndromic supernumerary kidneys, neonatal renal venous thrombosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.